SMAD2 and Hepatic fibrosis: Glycyrrhizic acid can not only inhibit SMAD2 and SMAD3 pathways mediated by TGF-β1 [39], but can also change the pathological morphology of the bile duct ligation model and prevent liver fibrosis [40].